• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC NEUROSURGERY STRATA II SNAP SHUNT ASSEMBLY, SMALL; SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC NEUROSURGERY STRATA II SNAP SHUNT ASSEMBLY, SMALL; SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS Back to Search Results
Model Number 27816
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Abnormal Blood Gases (1034); Bacterial Infection (1735); Cardiac Arrest (1762); Death (1802); Septic Shock (2068); Complaint, Ill-Defined (2331)
Event Date 05/12/2017
Event Type  Death  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported the patient was prematurely delivered on (b)(6).It was stated the patient suffered a grade iv left sided intraventricular hemorrhage, giving way to hydrocephalus, which required a series of lumbar taps; a reservoir was placed (b)(6) 2017.The treating neurologist planned for the patient to receive a vp shunt when they reached (b)(6).They fought off several serious infections before they reached that goal.Despite the setbacks, the patient gained weight and reached (b)(6) on or about (b)(6) 2017.The treating neurologist determined that the vp shunt surgery could be performed, and the patient was implanted.According to the operative reports, the patient received a programmable valve with a snap reservoir dome.By the time several measures were taken to save the patient's life, they spiraled into metabolic acidosis and disseminated intravascular coagulopathy (dic).From the morning of the vp shunt surgery on (b)(6) 2017, the patient was constantly treated for many symptoms of the massive and fatal infection.The patient died after unsuccessful cpr efforts.The cause of death was stated as cardiac arrest due to septic shock due to vp shunt infection.The autopsy report isolated the gram-negative organism in the brain, and within the catheter of the shunt as serratia.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information received reported that there was history of maternal chorioamnionitis and presumed neonatal meningitis.Serial ultrasounds demonstrated grade iv intraventricular hemorrhage with increasing hydrocephalus.Ultrasound on (b)(6) 2017 noted significant increase in ventricular dilatation with residual blood products in both lateral ventricles.On (b)(6) 2017, a right frontal insertion of ventricular catheter with subcutaneous reservoir was placed when the infant reached a weight of (b)(6), to help periodically drain csf.There were no complications and the baby was in stable condition after the procedure.On (b)(6) 2017, when the infant wight was above 2500 grams, the right frontal ventricular catheter reservoir was removed and a ventriculoperitoneal shunt was placed.Again there were no complications and the baby tolerated the procedure well.Not long after the ventriculoperitoneal shunt placement, cultures of the csf from a shunt tap (collected (b)(6) 2017) grew gram negative bacilli, specifically serratia marcescens, consistent with vp shunt infection.He was given broad spectrum antibiotics, neupogen and ivig; however, he continued to have worsening neutropenia and metabolic acidosis.He went into cardiac arrest and resuscitation efforts were initiated.However, given the critical status resuscitation was stopped and the baby passed away on (b)(6) 2017.The autopsy summary stated that a specific source for the infection was not entirely clear, given there were multiple possible primary sites.Postmortem examination of the gi tract showed no evidence of perforation, necrosis or enterocolitis, but approximately 40cc of serosanguinous peritoneal fluid was removed and cultures of peritoneal fluid grew serratia marcescens.Histologic sections of the brain showed a focal area of gram negative bacilli and cultures of csf fluid grew serratia marcescens.Histologic sections of the lungs showed features of acute damage, including alveolar hemorrhage, fibrinous material within alveolar spaces and focal hyaline membranes, as well as gram negative bacilli within alveolar spaces.No postmortem lung cultures were performed, but it was presumed the gram negative bacilli were likely serratia marcescens given the other findings.The cause of death was most likely respiratory insufficiency complicated by premature birth with very low birth weight, hydrocephalus with vp shunt infection and pulmonary infection with alveolar damage.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STRATA II SNAP SHUNT ASSEMBLY, SMALL
Type of Device
SHUNT, CENTRAL NERVOUS SYSTEM AND COMPONENTS
Manufacturer (Section D)
MEDTRONIC NEUROSURGERY
125 cremona drive
goleta CA 93117
Manufacturer (Section G)
MEDTRONIC NEUROSURGERY
125 cremona drive
goleta CA 93117
Manufacturer Contact
katcha taylor
9775 toledo way
irvine,ca, MN 92618
7635263305
MDR Report Key8625868
MDR Text Key145594679
Report Number2021898-2019-00188
Device Sequence Number1
Product Code JXG
UDI-Device Identifier00643169010529
UDI-Public00643169010529
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K042465
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 10/14/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date03/31/2019
Device Model Number27816
Device Catalogue Number27816
Device Lot NumberE11577
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 05/13/2019
Initial Date FDA Received05/20/2019
Supplement Dates Manufacturer Received09/19/2019
Supplement Dates FDA Received10/14/2019
Date Device Manufactured05/16/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age2 MO
Patient Weight3
-
-